Alopecia News and Research

RSS
Alopecia is the lack or loss of hair from areas of the body where hair is usually found. Alopecia can be a side effect of some cancer treatments.
Geneticists decipher new gene responsible for rare form of hair loss

Geneticists decipher new gene responsible for rare form of hair loss

Cooling therapies may offer best protection against adverse effects of taxane-based chemotherapy

Cooling therapies may offer best protection against adverse effects of taxane-based chemotherapy

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Researchers develop new wearable photostimulator that speeds up hair growth

Researchers develop new wearable photostimulator that speeds up hair growth

Gene linked to hair loss could be exploited to improve cancer immunotherapy

Gene linked to hair loss could be exploited to improve cancer immunotherapy

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Simple DNA test can predict risk of bad side effects to thiopurine drugs

Simple DNA test can predict risk of bad side effects to thiopurine drugs

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Baldness treatment using a medication for osteoporosis

Baldness treatment using a medication for osteoporosis

Researchers make key discovery about cellular pathway linked to myriad of diseases

Researchers make key discovery about cellular pathway linked to myriad of diseases

African-American women with a common form of hair loss linked to greater risk for uterine fibroids

African-American women with a common form of hair loss linked to greater risk for uterine fibroids

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Researchers identify mechanism that regulates signaling events leading to cancer metastasis

Researchers identify mechanism that regulates signaling events leading to cancer metastasis

Study reveals link of male-pattern baldness and premature graying with early heart disease

Study reveals link of male-pattern baldness and premature graying with early heart disease

FDA grants approval to first treatment for rare blood cancer

FDA grants approval to first treatment for rare blood cancer

Cleveland Clinic selects Paxman Scalp Cooling System as one of top medical innovations for 2018

Cleveland Clinic selects Paxman Scalp Cooling System as one of top medical innovations for 2018